Correction: ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis
Katarzyna Bogucka(Krakow Cardiovascular Research Institute), Krishnaraj Rajalingam(Johannes Gutenberg University Mainz), Janine Schloeder(Johannes Gutenberg University Mainz), Margarita Schlackow, Helmut Jonuleit(Johannes Gutenberg University Mainz), Sebastian Rosigkeit(Johannes Gutenberg University Mainz), Fédérico Marini(Johannes Gutenberg University Mainz), Kerstin A. David(University of Hawaiʻi at Mānoa)
Cited by 0
Related Papers
Detection and quantification of mutations in the plasma of patients with colorectal tumors
|Proceedings of the National Academy of Sciences|2005|1.2k
Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision
|BioTechniques|2004|229
What establishes a protein as an allergen?
|Journal of Chromatography B Biomedical Sciences and Applications|2001|111
Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo
|Nature Immunology|2015|111